INHERITED BONE MARROW FAILURE SYNDROME
Clinical trials for INHERITED BONE MARROW FAILURE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new INHERITED BONE MARROW FAILURE SYNDROME trials appear
Sign up with your email to follow new studies for INHERITED BONE MARROW FAILURE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to stop Cancer's return after transplant
Disease control Recruiting nowThis study is testing whether a two-drug treatment given after a bone marrow transplant can help prevent leukemia and related blood cancers from coming back. It involves children and young adults up to age 39 who have had a transplant for conditions like acute myeloid leukemia (A…
Matched conditions: INHERITED BONE MARROW FAILURE SYNDROME
Phase: PHASE2 • Sponsor: Franziska Wachter • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Early trial tests common cancer drug for rare bleeding disorder
Disease control Recruiting nowThis early-stage study is testing whether a drug called imatinib, already used for some cancers, can help people with a specific inherited gene change (RUNX1 mutation). People with this mutation often bruise or bleed easily and have a higher lifetime risk of blood cancers. The ma…
Matched conditions: INHERITED BONE MARROW FAILURE SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Genetic sleuthing aims to catch blood cancers before they start
Knowledge-focused Recruiting nowThis study aims to find people at risk for developing blood cancers and bone marrow failure syndromes before they get sick. Researchers will use advanced genetic testing on blood, bone marrow, and saliva samples from up to 2,000 participants. The goal is to identify early warning…
Matched conditions: INHERITED BONE MARROW FAILURE SYNDROME
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Decade-Long hunt for cancer clues in rare genetic disorder
Knowledge-focused Recruiting nowThis study aims to understand how and why people with Fanconi anemia develop certain cancers, particularly in the mouth, throat, and genital areas. Researchers will regularly screen 200 participants aged 8 and older over 10 years to track early warning signs and disease progressi…
Matched conditions: INHERITED BONE MARROW FAILURE SYNDROME
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC